These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1621415)

  • 1. Recent observations regarding the pathogenesis of recurrent respiratory syncytial virus infections: implications for vaccine development.
    Salkind AR; Roberts NJ
    Vaccine; 1992; 10(8):519-23. PubMed ID: 1621415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.
    Chiba Y; Higashidate Y; Suga K; Honjo K; Tsutsumi H; Ogra PL
    J Med Virol; 1989 Jul; 28(3):133-9. PubMed ID: 2666570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
    Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
    Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine.
    Kakuk TJ; Soike K; Brideau RJ; Zaya RM; Cole SL; Zhang JY; Roberts ED; Wells PA; Wathen MW
    J Infect Dis; 1993 Mar; 167(3):553-61. PubMed ID: 8440926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development.
    Crowe JE
    Vaccine; 1995 Mar; 13(4):415-21. PubMed ID: 7793140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    Johnson TR; Graham BS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.
    Murphy BR; Prince GA; Collins PL; Van Wyke Coelingh K; Olmsted RA; Spriggs MK; Parrott RH; Kim HW; Brandt CD; Chanock RM
    Virus Res; 1988 Aug; 11(1):1-15. PubMed ID: 2845680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 inhibitor production by human mononuclear leukocytes and leukocyte subpopulations exposed to respiratory syncytial virus: analysis and comparison with the response to influenza virus.
    McCarthy DO; Domurat FM; Nichols JE; Roberts NJ
    J Leukoc Biol; 1989 Sep; 46(3):189-98. PubMed ID: 2788203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cells in respiratory syncytial virus (RSV) infection.
    Askonas BA; Openshaw P; Cannon M
    Adv Exp Med Biol; 1989; 257():9-17. PubMed ID: 2533461
    [No Abstract]   [Full Text] [Related]  

  • 11. The limited role of the human interferon system response to respiratory syncytial virus challenge: analysis and comparison to influenza virus challenge.
    Roberts NJ; Hiscott J; Signs DJ
    Microb Pathog; 1992 Jun; 12(6):409-14. PubMed ID: 1522795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies.
    Garg R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Vaccine; 2015 Mar; 33(11):1338-44. PubMed ID: 25637860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.
    Herlocher ML; Ewasyshyn M; Sambhara S; Gharaee-Kermani M; Cho D; Lai J; Klein M; Maassab HF
    Vaccine; 1999 Jan; 17(2):172-81. PubMed ID: 9987152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of infections with respiratory syncytial virus: the hopes and hurdles ahead.
    Hall CB
    Rev Infect Dis; 1980; 2(3):384-92. PubMed ID: 6997967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo.
    Domurat F; Roberts NJ; Walsh EE; Dagan R
    J Infect Dis; 1985 Nov; 152(5):895-902. PubMed ID: 2931491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospects of respiratory syncytial virus vaccines].
    Tarro G
    Ann Sclavo; 1980; 22(1):40-1. PubMed ID: 7247482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.
    Belshe RB; Van Voris LP; Mufson MA
    J Infect Dis; 1982 Mar; 145(3):311-9. PubMed ID: 7037983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
    J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
    van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
    J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live viral vaccines for respiratory and enteric tract diseases.
    Chanock RM; Murphy BR; Collins PL; Coelingh KV; Olmsted RA; Snyder MH; Spriggs MK; Prince GA; Moss B; Flores J
    Vaccine; 1988 Apr; 6(2):129-33. PubMed ID: 2838984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.